Sorafenib-Induced Psoriasiform Eruption in a Patient With Metastatic Thyroid Carcinoma

被引：0
|
作者：
Diamantis, Melissa L. [1 ]
Chon, Susan Y. [2 ]
机构：
[1] Univ Texas Houston, Sch Med, Houston, TX 77030 USA
[2] Univ Texas Houston, MD Anderson Canc Ctr, Dept Dermatol, Houston, TX 77030 USA
来源：
JOURNAL OF DRUGS IN DERMATOLOGY | 2010年 / 9卷 / 02期
关键词：
INFLAMMATION; INHIBITOR; SUNITINIB; RECEPTOR; THERAPY;
D O I：
暂无
中图分类号：
R75 [皮肤病学与性病学];
学科分类号：
100206 ;
摘要：
Sorafenib is a multikinase inhibitor that blocks tumor cell proliferation and angiogenesis and is used for the treatment of advanced renal cell carcinoma, unresectable hepatocellular carcinoma, and other solid tumors Various dermatologic side effects have been reported, most notably a hand-foot-skin reaction (HFSR) This is a case of a sorafenib-induced psoriasiform eruption in a patient with metastatic thyroid carcinoma This patient also developed cutaneous squamous cell carcinoma and HFSR in association with sorafenib To the authors' knowledge, a psoriasiform eruption due to sorafenib has not been reported in the literature and has important therapeutic implications
引用
收藏
页码：169 / 171
页数：3
相关论文
共 50 条
  • [21] Sorafenib-induced severe urticaria in a patient with hepatocellular cancer
    Musri, Fatma Yalcin
    Mutlu, Hasan
    Salim, Derya Kivrak
    Eryilmaz, Melek Karakurt
    Unal, Betul
    Tural, Deniz
    Coskun, Hasan Senol
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2016, 22 (02) : 350 - 353
  • [22] Sorafenib-induced pancreatitis
    Amar, Surabhi
    Wu, Kevin J.
    Tan, Winston W.
    MAYO CLINIC PROCEEDINGS, 2007, 82 (04) : 521 - 521
  • [23] Sorafenib-induced Acute on Chronic Liver Failure in a Patient with Hepatocellular Carcinoma After Microwave Ablation
    Malik, Anam Naveed
    Din, Asim Tameez Ud
    Chaudhary, Farooq Mohyud Din
    Quratulain, F. N. U.
    Siddiqui, Khaleeq H.
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2019, 11 (07)
  • [24] Sorafenib-Induced Erythema Multiforme Major and Severe Hepatic Failure in Metastatic Hepatocellular Carcinoma: A Case Report
    Abrini, Houda
    Amzerin, Mounia
    El Mrabet, Fatima Zahra
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (03)
  • [25] Sorafenib-induced erythema multiforme
    MacGregor, Jennifer L.
    Silvers, David N.
    Grossman, Marc E.
    Sherman, William H.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2007, 56 (03) : 527 - 528
  • [26] Development of skin hypopigmentation in a patient with metastatic papillary carcinoma thyroid treated with Sorafenib
    Hussain, Syed Zubair
    Asghar, Ali
    Ikram, Mubasher
    Islam, Najmul
    BMC ENDOCRINE DISORDERS, 2013, 13
  • [27] Development of skin hypopigmentation in a patient with metastatic papillary carcinoma thyroid treated with Sorafenib
    Syed Zubair Hussain
    Ali Asghar
    Mubasher Ikram
    Najmul Islam
    BMC Endocrine Disorders, 13
  • [28] Sorafenib-induced palmoplantar hyperkeratosis
    Lountzis, Nektarios I.
    Maroon, Michele S.
    JOURNAL OF DRUGS IN DERMATOLOGY, 2008, 7 (06) : 588 - 589
  • [29] Sorafenib in the Management of Metastatic Medullary Thyroid Carcinoma
    Seow, Cherng Jye
    Yeo, Pei Shan
    Ho, Wen Yang Benjamin
    Lee, Kok Seng Melvin
    Lim, Dao Ming Gerard
    Eu, Kar Mun
    Tan, Seng Kiong
    ENDOCRINE REVIEWS, 2014, 35 (03)
  • [30] Sorafenib-induced perforating folliculitis
    Tausend, William
    Hoyer, Paige
    Wagner, Keith
    Subrt, Adrian
    Kaltwasser, Kyle
    Goodwin, Brandon
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2017, 76 (06) : AB239 - AB239
12345